Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IRWD

Ironwood Pharmaceuticals Inc

May 10 • 03:28PM ET

7.01

Dollar change +0.27
Percentage change 3.93	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IJR CALF VTI VB IWM VXF VBK IBB LABU IJT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.79	Insider Own	3.15%	Shs Outstand	156.35M	Perf Week	-13.73%
Market Cap	1.11B	Forward P/E	9.10	EPS next Y	0.77	Insider Trans	-5.23%	Shs Float	153.96M	Perf Month	-12.55%
Income	-1052.12M	PEG	-	EPS next Q	0.19	Inst Own	104.12%	Short Float	13.04%	Perf Quarter	-54.28%
Sales	413.55M	P/S	2.69	EPS this Y	107.75%	Inst Trans	-3.31%	Short Ratio	4.38	Perf Half Y	-24.11%
Book/sh	-2.08	P/B	-	EPS next Y	54.00%	ROA	-132.00%	Short Interest	20.08M	Perf Year	-32.77%
Cash/sh	0.76	P/C	9.16	EPS next 5Y	-	ROE	-559.14%	52W Range	6.21 - 15.70	Perf YTD	-38.77%
Dividend Est.	-	P/FCF	6.08	EPS past 5Y	-28.37%	ROI	-670.29%	52W High	-55.38%	Beta	0.54
Dividend TTM	-	Quick Ratio	0.84	Sales past 5Y	5.56%	Gross Margin	99.56%	52W Low	12.80%	ATR (14)	0.43
Dividend Ex-Date	-	Current Ratio	0.82	EPS Y/Y TTM	-668.17%	Oper. Margin	39.17%	RSI (14)	32.61	Volatility	5.46% 4.17%
Employees	267	Debt/Eq	-	Sales Y/Y TTM	-0.86%	Profit Margin	-254.41%	Recom	1.17	Target Price	18.00
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-110.53%	Payout	-	Rel Volume	0.88	Prev Close	6.74
Sales Surprise	-29.19%	EPS Surprise	-114.85%	Sales Q/Q	-28.05%	Earnings	May 09 BMO	Avg Volume	4.58M	Price	7.01
SMA20	-11.59%	SMA50	-16.19%	SMA200	-31.53%	Trades		Volume	3,719,891	Change	3.93%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-17-24	Initiated	Craig Hallum	Buy	$21
Dec-14-23	Initiated	Wells Fargo	Overweight	$20
Nov-09-23	Initiated	Jefferies	Buy	$21
Sep-28-23	Initiated	JMP Securities	Mkt Outperform	$22
Sep-02-22	Initiated	CapitalOne	Overweight	$15
Apr-22-22	Initiated	Piper Sandler	Overweight	$16
Sep-30-20	Downgrade	Wells Fargo	Overweight → Equal Weight	$14 → $9
Jun-17-20	Initiated	Northland Capital	Outperform	$14
Jul-10-19	Resumed	Credit Suisse	Neutral
Mar-27-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-25-19	Upgrade	H.C. Wainwright	Sell → Neutral	$14
Jan-24-19	Upgrade	JP Morgan	Underweight → Neutral
Nov-07-18	Downgrade	JP Morgan	Neutral → Underweight
Nov-07-18	Downgrade	Credit Suisse	Outperform → Neutral
Jul-23-18	Initiated	H.C. Wainwright	Sell	$12.50
May-09-18	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jan-05-18	Downgrade	BofA/Merrill	Buy → Underperform
Dec-06-17	Downgrade	Mizuho	Buy → Neutral	$16
Jul-21-17	Downgrade	JP Morgan	Overweight → Neutral
May-03-17	Initiated	Wells Fargo	Outperform

Show Previous Ratings

Today 01:58PM	Ironwood Pharmaceuticals Reports Mixed Q1 2024 Results Amid Key Clinical Advancements (GuruFocus.com)
12:59PM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:16AM	Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates (Zacks)
May-09-24 03:59PM	Sector Update: Health Care Stocks Higher Late Afternoon (MT Newswires) -17.00%
01:55PM	Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading (MT Newswires)
01:39PM	Loading…
01:39PM	Sector Update: Health Care (MT Newswires)
11:57AM	IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:54AM	Ironwood Pharmaceuticals' Shares Fall After Q1 Swings to a Non-GAAP Loss, Revenue Declines; 2024 Revenue Guidance Cut (MT Newswires)
07:11AM	Ironwood: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports First Quarter 2024 Results (Business Wire)
May-06-24 04:01PM	Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference (Business Wire)
May-02-24 02:33PM	Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management (Newsfile)
10:01AM	Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline (Zacks)
May-01-24 07:30AM	Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week 2024 (Business Wire) +6.06%
Apr-30-24 01:16PM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Biotech Stocks (InvestorPlace)
04:01PM	Loading…
Apr-25-24 04:01PM	Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call (Business Wire)
Apr-21-24 10:39AM	5 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
Mar-28-24 07:30AM	Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD) (Business Wire)
Mar-05-24 01:05PM	Its Time! 3 Failing Biotech Stocks to Sell Right Now (InvestorPlace)
Feb-29-24 04:19PM	Ironwood Pharmaceuticals Ran Up 38% Over Three Months And Just Lost It All (Investor's Business Daily) -37.63%
08:37AM	Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today? (InvestorPlace)
06:26AM	UPDATE 1-Ironwood's bowel disease treatment meets main goal in late-stage trial (Reuters)
06:08AM	Ironwood says bowel disease treatment meets main goal in late-stage trial (Reuters)
06:00AM	Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF) (Business Wire)
Feb-23-24 07:30AM	Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference (Business Wire)
Feb-16-24 10:15AM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:36AM	Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally (Zacks)
Feb-15-24 10:45PM	Q4 2023 Ironwood Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
08:15AM	Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4 (Zacks)
07:26AM	Ironwood: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Loading…
07:00AM	Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance (Business Wire)
Feb-05-24 08:50AM	Ironwood (IRWD) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Feb-01-24 04:01PM	Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call (Business Wire)
Jan-23-24 09:55AM	Wall Street Analysts Think Ironwood (IRWD) Could Surge 37.6%: Read This Before Placing a Bet (Zacks)
Jan-08-24 07:00PM	Ironwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional Constipation (Business Wire)
06:00AM	Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance (Business Wire)
Jan-03-24 04:01PM	Ironwood Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-12-23 04:01PM	Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio (Business Wire)
Nov-30-23 09:45AM	Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management (Newsfile)
Nov-21-23 04:01PM	Ironwood Pharmaceuticals to Participate in the Piper Sandler 35th Annual Healthcare Conference (Business Wire)
Nov-10-23 02:45PM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:09AM	Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises (Zacks)
Nov-09-23 10:25PM	Q3 2023 Ironwood Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
08:39AM	Ironwood Pharmaceuticals Inc (IRWD) Reports Growth in LINZESS Sales and Maintains Full Year Guidance (GuruFocus.com)
07:46AM	Top 11 Extreme Value Stocks To Buy (Insider Monkey)
07:22AM	Ironwood: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports Third Quarter 2023 Results (Business Wire)
Oct-26-23 04:01PM	Ironwood Pharmaceuticals to Host Third Quarter 2023 Investor Update Call (Business Wire)
Oct-23-23 07:30AM	Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting (Business Wire)
Oct-17-23 12:02PM	Decoding Ownership and Performance: Ironwood Pharmaceuticals Inc(IRWD) (GuruFocus.com)
Oct-16-23 06:00AM	Ironwood Pharmaceuticals Presents Positive Final Data from STARS Nutrition, a Phase II Study of Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon in Continuity (CIC) at United European Gastroenterology Week (Business Wire)
Oct-05-23 07:30AM	Ironwood to Present New Data at NASPGHAN Annual Meeting Reinforcing Impact of Linaclotide on Functional Constipation in Children and Adolescents Ages 6-17 Years-Old (Business Wire)
Oct-03-23 11:43AM	Ironwood Pharmaceuticals (IRWD): A Hidden Gem or a Potential Risk? An In-Depth Look at Its Valuation (GuruFocus.com)
Oct-01-23 07:15AM	Here's How to Lock in a Trade on a Promising Biopharma Name (TheStreet.com)
Sep-26-23 11:48AM	Unveiling Ironwood Pharmaceuticals (IRWD)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-20-23 07:36AM	Ironwood (IRWD) Surges 7.6%: Is This an Indication of Further Gains? (Zacks)
Sep-19-23 12:08PM	Ironwood Pharmaceuticals Inc (IRWD): A Deep Dive into Its Performance Potential (GuruFocus.com) +7.55%
11:39AM	Ironwood Pharmaceuticals (IRWD): A Comprehensive Analysis of Its Market Value (GuruFocus.com)
Sep-12-23 08:32AM	Implied Volatility Surging for Ironwood (IRWD) Stock Options (Zacks)
Sep-07-23 11:30AM	Why Is Ironwood (IRWD) Down 9.6% Since Last Earnings Report? (Zacks)
Aug-12-23 08:50AM	Is There An Opportunity With Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) 49% Undervaluation? (Simply Wall St.)
Aug-09-23 09:24AM	Ironwood's (IRWD) Reports Q2 Loss, Linzess Volume Rises (Zacks) -6.79%
Aug-08-23 11:12PM	Q2 2023 Ironwood Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -9.16%
11:05AM	Ironwood Pharmaceuticals (IRWD) Q2 Earnings and Revenues Surpass Estimates (Zacks)
09:56AM	Ironwood: Q2 Earnings Snapshot (AP Finance)
07:00AM	Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance (Business Wire)
Jul-28-23 02:56PM	10 Best Small Cap Pharma Stocks to Buy (Insider Monkey)
Jul-25-23 04:01PM	Ironwood Pharmaceuticals to Host Second Quarter 2023 Investor Update Call (Business Wire)
Jun-29-23 08:30AM	Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares (Business Wire)
Jun-21-23 08:00PM	IRWD: Lowering target price to $11.00 (Argus Research)
Jun-16-23 07:00AM	Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio (Business Wire)
Jun-13-23 09:18AM	Ironwood (IRWD), AbbVie Get FDA Nod for Linzess Label Expansion (Zacks)
Jun-12-23 04:05PM	Ironwood Pharmaceuticals Announces FDA Approval of New Indication for LINZESS® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients Ages 6-17 Years-Old (Business Wire)
09:54AM	Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround (Motley Fool)
May-25-23 10:32AM	Biotech Stock Roundup: IRWD Announces Buyout, ICPT, SRPT & PTCT Fall on Updates (Zacks)
May-23-23 12:07PM	Ironwood (IRWD) to Acquire VectivBio for $1B, Stock Up 3.6% (Zacks)
May-22-23 05:43PM	Why Ironwood Pharmaceuticals Stock Bumped Higher Today (Motley Fool)
04:08PM	VectivBio Stock Catapults 39% After Ironwood Agrees To Buy It For $1 Billion (Investor's Business Daily)
01:11PM	Ironwood spends $1B to acquire Swiss biotech (American City Business Journals)
12:02PM	Why Shares of VectivBio Holding Are Up Today (Motley Fool)
08:40AM	Ironwood Pharmaceuticals to Buy VectivBio in $1 Billion Deal. The Sector Is Hot for M&A. (Barrons.com)
07:24AM	UPDATE 1-Ironwood Pharma to acquire VectivBio for $1.15 bln (Reuters)
07:22AM	Ironwood bulks up on digestive therapies with $1.15 billion VectivBio buy (Reuters)
06:57AM	Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases (Business Wire)
May-09-23 04:01PM	Ironwood Pharmaceuticals to Participate in The JMP Securities Life Sciences Conference (Business Wire)
May-08-23 07:30AM	Ironwood Presents New Data on Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old at Digestive Disease Week® 2023 (Business Wire)
May-05-23 09:31AM	Ironwood (IRWD) Q1 Earnings Beat Estimates, Linzess Volume Up (Zacks)
May-04-23 08:55AM	Ironwood Pharmaceuticals (IRWD) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:00AM	Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance (Business Wire)
Apr-26-23 08:00PM	IRWD: What does Argus have to say about IRWD? (Argus Research)
Apr-24-23 07:30AM	Ironwood to Present New Data at Digestive Disease Week® 2023 Demonstrating Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old (Business Wire)
Apr-20-23 04:01PM	Ironwood Pharmaceuticals to Host First Quarter 2023 Investor Update Call (Business Wire)
Mar-22-23 02:53PM	Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? (Simply Wall St.)
Mar-14-23 02:56AM	Strength Seen in Xencor (XNCR): Can Its 5.3% Jump Turn into More Strength? (Zacks)
Mar-02-23 07:09AM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Could Be 40% Below Their Intrinsic Value Estimate (Simply Wall St.)
Feb-27-23 04:01PM	Ironwood Pharmaceuticals to Participate in Upcoming Investor Conferences (Business Wire)
Feb-20-23 07:40AM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2022 Earnings Call Transcript (Insider Monkey)
Feb-17-23 11:11AM	Ironwood (IRWD) Q4 Earnings Miss, Linzess Volume Increases (Zacks)
Feb-16-23 08:35AM	Ironwood Pharmaceuticals (IRWD) Misses Q4 Earnings and Revenue Estimates (Zacks)
07:00AM	Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results (Business Wire)

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Shetzline Michael	CMO,SVP,Head-Res&Drug	Mar 08 '24	Option Exercise	0.00	34,936	0	429,847	Mar 12 04:05 PM
John Minardo	Chief Legal Officer	Mar 08 '24	Option Exercise	0.00	32,752	0	311,975	Mar 12 04:05 PM
MCCOURT Thomas A	Chief Executive Officer	Mar 08 '24	Option Exercise	0.00	120,298	0	1,217,948	Mar 12 04:05 PM
Davis Andrew	SVP, Chief Business Officer	Mar 08 '24	Option Exercise	0.00	37,120	0	310,756	Mar 12 04:05 PM
Emany Sravan Kumar	SVP, Chief Financial Officer	Mar 08 '24	Option Exercise	0.00	37,120	0	338,853	Mar 12 04:05 PM
Duane Jon R	Director	Mar 06 '24	Buy	8.70	6,920	60,204	121,028	Mar 08 04:05 PM
Emany Sravan Kumar	SVP, Chief Financial Officer	Mar 04 '24	Buy	9.38	10,684	100,216	301,733	Mar 06 04:05 PM
MCCOURT Thomas A	Chief Executive Officer	Feb 12 '24	Sale	15.24	177,164	2,699,979	832,774	Feb 14 08:35 PM
John Minardo	Chief Legal Officer	Feb 12 '24	Sale	15.24	47,380	722,071	224,796	Feb 14 09:01 PM
Shetzline Michael	CMO,SVP,Head-Res&Drug	Feb 12 '24	Sale	15.24	38,618	588,538	340,484	Feb 14 08:53 PM
Davis Andrew	SVP, Chief Business Officer	Feb 12 '24	Sale	15.24	9,846	150,053	208,324	Feb 14 08:42 PM
Silver Ronald	Principal Accounting Officer	Feb 12 '24	Sale	15.24	7,908	120,518	134,264	Feb 14 08:50 PM
Kessler Marla L	Director	Dec 14 '23	Sale	11.19	9,926	111,072	96,572	Dec 18 04:09 PM
Davis Andrew	SVP, Chief Business Officer	Nov 20 '23	Sale	9.69	3,287	31,851	217,374	Nov 22 04:05 PM
Emany Sravan Kumar	SVP, Chief Financial Officer	Sep 15 '23	Buy	8.32	36,072	300,119	188,730	Sep 18 05:07 PM
John Minardo	Chief Legal Officer	Aug 14 '23	Sale	10.04	7,045	70,732	192,195	Aug 16 04:20 PM
Silver Ronald	Principal Accounting Officer	Aug 14 '23	Sale	10.04	1,976	19,839	134,172	Aug 16 04:21 PM
MCCOURT Thomas A	Chief Executive Officer	May 30 '23	Sale	10.70	26,632	284,962	758,284	Jun 01 05:45 PM
MCCOURT Thomas A	Chief Executive Officer	May 22 '23	Sale	10.12	36,000	364,320	784,916	May 24 04:05 PM
Shetzline Michael	CMO,SVP,Head-Res&Drug	May 22 '23	Sale	10.12	10,324	104,479	321,131	May 24 04:05 PM
Davis Andrew	SVP, Chief Business Officer	May 22 '23	Sale	10.12	6,305	63,807	219,327	May 24 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IRWD

Ironwood Pharmaceuticals Inc

Upgrade your FINVIZ experience